---
title: "Merck & Co. Inc. Stock Underperforms Monday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291842050.md"
description: "Merck & Co. (MRK) shares fell 2.15% to $126.78 on Monday, underperforming the broader market as the S&P 500 and Dow Jones rose. The stock closed 2.69% below its 52-week high of $130.29. Trading volume was lower than the 50-day average. Compared to competitors, Merck's decline was steeper than Johnson & Johnson and Eli Lilly but milder than Pfizer."
datetime: "2026-07-06T20:33:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291842050.md)
  - [en](https://longbridge.com/en/news/291842050.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291842050.md)
---

# Merck & Co. Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Merck & Co. Inc. (MRK) shed 2.15% to $126.78 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.72% to 7,537.43 and the Dow Jones Industrial Average rising 0.29% to 53,055.91.

Merck & Co. Inc. closed 2.69% short of its 52-week high of $130.29, which the company reached on June 30th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 1.41% to $259.33, Pfizer Inc. (PFE) fell 2.47% to $23.72, and Eli Lilly & Co. (LLY) fell 1.14% to $1,200.06.

Trading volume (9.2 M) remained 1.4 million below its 50-day average volume of 10.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 6, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-06-26 1633ET

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Aspen Pharmacare signs voluntary licensing deal with MSD for once-monthly HIV prevention pill MK-8527](https://longbridge.com/en/news/293755123.md)
- [Littlejohn Financial Services Inc. Sells 10,589 Shares of Merck & Co., Inc. $MRK](https://longbridge.com/en/news/291126196.md)
- [Better dividend king to buy right now: AbbVie or Johnson & Johnson?](https://longbridge.com/en/news/293843937.md)
- [Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your Portfolio](https://longbridge.com/en/news/293257595.md)
- [RFG Advisory LLC Trims Stock Position in Merck & Co., Inc. $MRK](https://longbridge.com/en/news/290937545.md)